These final results, along with a prior report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assistance the notion of focusing on ACKR3 as a unique strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-asso